# The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia

Study · id `cardio:ct-nct03288038` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03288038](<https://clinicaltrials.gov/study/NCT03288038>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03288038

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 382 participants.

## Technical summary

Registry record NCT03288038. Randomized; double masking; primary purpose treatment. Start 2014-10-13 (actual); primary completion 2015-11-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 382 participants (enrolled count; ClinicalTrials.gov record NCT03288038, source copy `cardio:ctgov-nct03288038-2017-09-19`, retrieved 2026-10-31)
- Started: 2014-10-13 (actual) (ClinicalTrials.gov record NCT03288038, source copy `cardio:ctgov-nct03288038-2017-09-19`, retrieved 2026-10-31)
- Primary completion: 2015-11-19 (actual) (ClinicalTrials.gov record NCT03288038, source copy `cardio:ctgov-nct03288038-2017-09-19`, retrieved 2026-10-31)
- Completion: 2015-11-19 (actual) (ClinicalTrials.gov record NCT03288038, source copy `cardio:ctgov-nct03288038-2017-09-19`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT03288038, source copy `cardio:ctgov-nct03288038-2017-09-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03288038-2017-09-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
- Condition: Hypercholesterolemia
- Intervention (Drug): Rosuvastatin
- Intervention (Drug): Ezetimibe
- Lead sponsor: Shin Poong Pharmaceutical Co. Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention name matches this record: Ezetimibe (`cardio:ezetimibe`)
- Registry lists this organization as the lead sponsor: Shin Poong Pharmaceutical Co. Ltd. (`cardio:org-shin-poong-pharmaceutical-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia (`cardio:pubmed-29857919`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c6054039706bf3d5ff2f5cac64d056292ac4aadaf145a14d74233b752e6a0ce0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
